Equitable Trust CO Laboratory Corp Of America Holdings Transaction History

Equitable Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$209.01 - $232.56 $845,027 - $940,240	-4,043 Reduced 3.08%	127,199 $27.8 Million
Q4 2023 Jan 25, 2024	BUY	$197.69 - $227.29 $3.42 Million - $3.93 Million	17,298 Added 15.18%	131,242 $29.8 Million
Q3 2023 Nov 07, 2023	BUY	$201.05 - $221.7 $5.69 Million - $6.27 Million	28,280 Added 33.01%	113,944 $22.9 Million
Q2 2023 Aug 09, 2023	BUY	$211.93 - $241.33 $1.93 Million - $2.2 Million	9,115 Added 11.91%	85,664 $20.7 Million
Q1 2023 May 08, 2023	BUY	$213.32 - $257.83 $4.34 Million - $5.24 Million	20,332 Added 36.17%	76,549 $17.6 Million
Q4 2022 Feb 21, 2023	BUY	$203.72 - $248.97 $11.5 Million - $14 Million	56,217 New	56,217 $13.2 Million

130

2.5M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

Stay updated on Equitable Trust CO with notifications on news.